Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
Recruiting · NCT05955924 · Registry updated 2025-02-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial | Keratinocyte Carcinoma, Neoplasms by Histologic Type, basal cell carcinoma, basal cell neoplasm, carcinoma, epithelial neoplasm, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 3 | 2025-02-21 | NCT05955924 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Institutes of Health Research (CIHR) | 339 |
| NOW Foods | 1 |
| University Health Network, Toronto | 417 |
| Women's College Hospital | 31 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| St. Paul's Hospital | Vancouver | Canada | 28 |
| The Ottawa Hospital | Ottawa | Canada | 15 |
| Toronto General Hospital | Toronto | Canada | 42 |
| University of Alberta | Edmonton | Canada | 23 |
| University of Calgary | Calgary | Canada | 44 |
| Vancouver General Hospital | Vancouver | Canada | 53 |
| Women's College Hospital | Toronto | Canada | 25 |